|
|
|
|
Bright Minds Biosciences Inc (DRUG) |
|
|
|
| |
Bright Minds Biosciences Inc 's Working Capital Ratio
DRUG's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth
Regardless of the sequential decrease in Current Liabilities, during the forth quarter 2023, Working Capital Ratio deteriorated to 24.26 above company average Working Capital Ratio.
Within Major Pharmaceutical Preparations industry 27 other companies have achieved higher Working Capital Ratio than Bright Minds Biosciences Inc in forth quarter 2023. While Working Capital Ratio total ranking in the forth quarter 2023 has deteriorated compared to the prior quarter from 166 to 175.
Explain Working Capital Ratio
How much in Current Assets DRUG´s has?
What is the value of DRUG´s Current Liabilities?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| DRUG Working Capital Ratio |
(Sep 30 2023)
IV. Quarter |
0
III. Quarter |
0
II. Quarter |
0
I. Quarter |
(Sep 30 2022)
IV. Quarter |
| Y / Y Current Liabilities Change |
-80.93 % |
-80.93 % |
-80.93 % |
-80.93 % |
- |
| Y / Y Current Assets Change |
-42.98 % |
-42.98 % |
-42.98 % |
-42.98 % |
- |
| Working Capital Ratio MRQ |
24.26 |
24.26 |
24.26 |
24.26 |
8.11 |
| DRUG's Total
Ranking |
# 175 |
# 166 |
# 169 |
# 169 |
# 538 |
| Seq. Current Liabilities Change |
0 % |
0 % |
0 % |
-80.93 % |
0 % |
| Seq. Current Assets Change |
0 % |
0 % |
0 % |
-42.98 % |
0 % |
| Working Capital Ratio forth quarter 2023 Company Ranking |
| Within: |
No. |
| Major Pharmaceutical Preparations Industry |
# 28 |
| Healthcare Sector |
# 44 |
| Overall Market |
# 175 |
| Working Capital Ratio Statistics |
| High |
Average |
Low |
| 24.26 |
16.19 |
8.11 |
| (Sep 30 2023) |
|
(Sep 30 2022) |
Cumulative Bright Minds Biosciences Inc 's Working Capital Ratio
DRUG's Working Capital Ratio for the trailling 12 Months
DRUG Working Capital Ratio |
(Sep 30 2023)
IV. Quarter |
0
III. Quarter |
0
II. Quarter |
0
I. Quarter |
(Sep 30 2022)
IV. Quarter |
| Y / Y Current Liabilities TTM Growth |
-80.93 % |
-80.93 % |
-80.93 % |
-80.93 % |
- |
| Y / Y Current Assets TTM Growth |
-42.98 % |
-42.98 % |
-42.98 % |
-42.98 % |
- |
| Working Capital Ratio TTM |
24.26 |
13.99 |
10.7 |
9.08 |
8.11 |
| Total
Ranking TTM |
# 3804
| # 3762
| # 3832
| # 3851
| # 570
|
| Seq. Current Liabilities TTM Growth |
0 % |
0 % |
0 % |
-80.93 % |
0 % |
| Seq. Current Assets TTM Growth |
0 % |
0 % |
0 % |
-42.98 % |
0 % |
On the trailing twelve months basis Current Liabilities decreased faster than Bright Minds Biosciences Inc 's average Current Assets, this led to increase in in Bright Minds Biosciences Inc 's Working Capital Ratio to 24.26, above DRUG average Working Capital Ratio. Working Capital Ratio is the average cumulative value over the last four quarters.
Among companies operating within Major Pharmaceutical Preparations industry 502 other companies have achieved higher Working Capital Ratio than Bright Minds Biosciences Inc . While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2023 from 3762 to 3804.
Explain Working Capital Ratio
How much in Current Assets DRUG´s has?
What is the value of DRUG´s Current Liabilities?
| TTM Working Capital Ratio Company Ranking |
| Within: |
No. |
| Within the Major Pharmaceutical Preparations Industry |
# 503 |
| Healthcare Sector |
# 1026 |
| Within the Market |
# 3804 |
| trailing twelve months Working Capital Ratio Statistics |
| High |
Average |
Low |
| 24.26 |
12.38 |
8.11 |
| (Sep 30 2023) |
|
(Sep 30 2022) |
|
Date modified: 2024-01-19T12:02:42+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
